DEVELOPMENT PIPELINE

PrTMS has not been evaluated in clinical research studies to date. However, PeakLogic plans to pursue studies evaluating use of the PrTMS protocol for the treatment of major mental health and neurocognitive disorders, including human performance. PeakLogic also hopes to pursue FDA-clearance of new products that may improve TMS therapy more broadly.

PeakLogic plans to research the potential safety and efficacy of PrTMS for a variety of conditions, including: